专利检索 ap:("SHANGHAI YINGLI PHARMACEUTICAL CO LTD") AND inv:"WU TIANZHI" 第 1 页

1.

发明公开
CONDENSED RING DERIVATIVE, AND PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE THEREOF 审中-公开

公开(公告)号：EP3275867A4

公开(公告)日：2018-01-31

申请号：EP16767632

申请日：2016-02-01

申请人： SHANGHAI YINGLI PHARMACEUTICAL CO LTD

发明人： XU ZUSHENG , ZHANG NONG , SUN QINGRUI , WU TIANZHI

IPC分类号： C07D217/00 , A61K31/472 , A61K31/517 , A61P3/00 , C07D231/56 , C07D237/30 , C07D239/78 , C07D333/60 , C07D405/04 , C07D471/04 , C07D495/04

CPC分类号： A61K31/472 , A61K31/517 , C07D217/00 , C07D231/56 , C07D237/30 , C07D239/78 , C07D333/60 , C07D405/04 , C07D471/04 , C07D495/04

摘要： Disclosed are a condensed ring derivative, and a preparation method, an intermediate, a pharmaceutical composition and a use thereof. The condensed ring derivative of the present invention has a significant inhibitive effect on URAT1, which can effectively alleviate or treat hyperuricemia and other related diseases.